Cartesian Therapeutics
RNAC
#7523
Rank
โ‚น25.10 B
Marketcap
โ‚น968.97
Share price
11.28%
Change (1 day)
-11.34%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -โ‚น6.47 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are โ‚น38.91 Million. , an increase over its 2023 earnings that were of -โ‚น20.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น6.65 Billion-67.3%
2023 -โ‚น20.32 Billion-724%
2022 โ‚น3.25 B-649.67%
2021 -โ‚น0.6 Billion-89.78%
2020 -โ‚น5.8 Billion25.06%
2019 -โ‚น4.64 Billion-15.68%
2018 -โ‚น5.5 Billion-0.43%
2017 -โ‚น5.53 Billion83.41%
2016 -โ‚น3.02 Billion44.3%
2015 -โ‚น2.09 Billion